Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARBARA J MIGLICCO MILLER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1457499253
CMS profile
10734089
Location
WAXAHACHIE, TX

General Payments · PY2021–2024

$749.65

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$326.83

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $326.83 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $151.47 11
Boehringer Ingelheim Pharmaceuticals, Inc. $98.89 1
ITI, Inc. $44.78 2
Takeda Pharmaceuticals U.S.A., Inc. $15.89 1
Noven Therapeutics, LLC $15.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $38.15 2
PY2022 $223.90 8
PY2023 $160.77 8
PY2024 $326.83 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $10.75 01/11/2024 Food and Beverage Undisputed 01/23/2026 1107659186 CMS
ABBVIE INC. $13.44 02/01/2024 Food and Beverage Undisputed 01/23/2026 1107659188 CMS
ABBVIE INC. $4.86 02/22/2024 Food and Beverage Undisputed 01/23/2026 1107659190 CMS
ABBVIE INC. $16.63 03/14/2024 Food and Beverage Undisputed 01/23/2026 1107659192 CMS
ABBVIE INC. $24.57 04/11/2024 Food and Beverage Undisputed 01/23/2026 1107659194 CMS
ABBVIE INC. $5.03 05/09/2024 Food and Beverage Undisputed 01/23/2026 1107659196 CMS
ABBVIE INC. $20.06 06/06/2024 Food and Beverage Undisputed 01/23/2026 1107659198 CMS
ABBVIE INC. $9.60 07/11/2024 Food and Beverage Undisputed 01/23/2026 1107659200 CMS
ABBVIE INC. $17.18 08/16/2024 Food and Beverage Undisputed 01/23/2026 1107659202 CMS
ABBVIE INC. $10.08 10/24/2024 Food and Beverage Undisputed 01/23/2026 1107659204 CMS
ABBVIE INC. $19.27 12/05/2024 Food and Beverage Undisputed 01/23/2026 1107659206 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $98.89 11/08/2024 Food and Beverage Undisputed 01/23/2026 1118017018 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.74 02/29/2024 Food and Beverage Undisputed 01/23/2026 1143551532 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.04 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143551535 CMS
Noven Therapeutics, LLC $15.80 03/07/2024 Food and Beverage Undisputed 01/23/2026 1084828250 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.89 06/11/2024 Food and Beverage Undisputed 01/23/2026 1137792685 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.